Cascadian Therapeutics Added to the Nasdaq Biotechnology Index
13 déc. 2017 08h35 HE
|
Cascadian Therapeutics, Inc.
SEATTLE, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (Nasdaq:CASC), a clinical-stage biopharmaceutical company, today announced that it has been selected for addition to the...